AstraZeneca CFO quits for Goldman
Jon Symonds, chief financial officer of AstraZeneca, is leaving the pharmaceutical group to join Goldman Sachs, as the bank looks to capitalise on his high-level influence at UK companies.
Jon Symonds, chief financial officer of AstraZeneca, is leaving the pharmaceutical group to join Goldman Sachs, as the bank looks to capitalise on his high-level influence at UK companies.
Copyright PEI Media
Not for publication, email or dissemination